Mizoguchi Hirokazu, Takagi Hirokazu, Watanabe Chizuko, Yonezawa Akihiko, Sato Takumi, Sakurada Tsukasa, Sakurada Shinobu
Peptides. 2014 Jan;51:15-25. doi: 10.1016/j.peptides.2013.10.012.
The involvement of the μ-opioid receptor subtypes on the presynaptic or postsynaptic inhibition of spinal pain transmission was characterized in ddY mice using endomorphins. Intrathecal treatment with capsaicin, N-methyl-d-aspartate (NMDA) or substance P elicited characteristic nociceptive behaviors that consisted primarily of vigorous biting and/or licking with some scratching. Intrathecal co-administration of endogenous μ-opioid peptide endomorphin-1 or endomorphin-2 resulted in a potent antinociceptive effect against the nociceptive behaviors induced by capsaicin, NMDA or substance P, which was eliminated by i.t. co-administration of the μ-opioid receptor antagonist D-Phe-Cys-Tyr-D-Trp-Orn-Thr-Pen-Thr-NH2 (CTOP). The antinociceptive effect of endomorphin-1 was significantly suppressed by i.t.-co-administration of the μ2-opioid receptor antagonist Tyr-D-Pro-Trp-Phe-NH2 (D-Pro2-endomorphin-1) but not the μ1-opioid receptor antagonist Tyr-D-Pro-Phe-Phe-NH2 (D-Pro2-endomorphin-2) on capsaicin- or NMDA-elicited nociceptive behaviors. In contrast, the antinociceptive effect of endomorphin-2 was significantly suppressed by i.t.-co-administration of D-Pro2-endomorphin-2 but not D-Pro2-endomorphin-1 on capsaicin-, NMDA- or substance P-elicited nociceptive behaviors. Interestingly, regarding substance P-elicited nociceptive behaviors, the antinociceptive effect of endomorphin-1 was significantly suppressed by i.t.-co-administration of another μ2-opioid receptor antagonist, Tyr-D-Pro-Trp-Gly-NH2 (D-Pro2-Tyr-W-MIF-1), but not D-Pro2-endomorphin-1 or D-Pro2-endomorphin-2. The present results suggest that the multiple μ-opioid receptor subtypes are involved in the presynaptic or postsynaptic inhibition of spinal pain transmission.
使用内吗啡肽在ddY小鼠中研究了μ-阿片受体亚型在脊髓痛觉传递的突触前或突触后抑制中的作用。鞘内注射辣椒素、N-甲基-D-天冬氨酸(NMDA)或P物质会引发特征性的伤害性反应,主要包括剧烈咬和/或舔以及一些抓挠动作。鞘内共同给予内源性μ-阿片肽内吗啡肽-1或内吗啡肽-2会对辣椒素、NMDA或P物质诱导的伤害性反应产生强效的抗伤害作用,而鞘内共同给予μ-阿片受体拮抗剂D-苯丙氨酸-半胱氨酸-酪氨酸-D-色氨酸-鸟氨酸-苏氨酸-青霉胺-苏氨酸-氨基(CTOP)可消除这种作用。对于辣椒素或NMDA引发的伤害性反应,鞘内共同给予μ2-阿片受体拮抗剂酪氨酸-D-脯氨酸-色氨酸-苯丙氨酸-氨基(D-脯氨酸2-内吗啡肽-1)可显著抑制内吗啡肽-1的抗伤害作用,而μ1-阿片受体拮抗剂酪氨酸-D-脯氨酸-苯丙氨酸-苯丙氨酸-氨基(D-脯氨酸2-内吗啡肽-2)则无此作用。相反,对于辣椒素、NMDA或P物质引发的伤害性反应,鞘内共同给予D-脯氨酸2-内吗啡肽-2可显著抑制内吗啡肽-2的抗伤害作用,而D-脯氨酸2-内吗啡肽-1则无此作用。有趣的是,对于P物质引发的伤害性反应,鞘内共同给予另一种μ2-阿片受体拮抗剂酪氨酸-D-脯氨酸-色氨酸-甘氨酸-氨基(D-脯氨酸2-酪氨酸-W-MIF-1)可显著抑制内吗啡肽-1的抗伤害作用,而D-脯氨酸2-内吗啡肽-1或D-脯氨酸2-内吗啡肽-2则无此作用。目前的结果表明,多种μ-阿片受体亚型参与了脊髓痛觉传递的突触前或突触后抑制。